Hosted on MSN

Inside Altos Labs: the biotech titan cracking the code to the elixir of youth

It is one of humanity’s ultimate scientific and technological quests, alongside putting a man on the moon and unlocking the structure of DNA. Now the biotech industry’s progress in developing ...
The New York Times

Longevity Science Is Overhyped. But This Research Really Could Change Humanity.

A new therapy has the potential to cure hundreds of diseases — and even reverse aging. Credit...Photo illustration by Kensuke Koike Supported by By Susan Dominus Why are babies born young? The most ...
EurekAlert!

Announcing Altos Labs as Tier 5 Sponsor of ARDD 2024

Empowering the future of aging research: Altos Labs to sponsor ARDD 2024, the world's largest conference on aging research in the biopharmaceutical industry Altos Labs™ (Altos™) is a biotechnology ...
EurekAlert!

Oncoscience: Altos Labs and the quest for immortality - Dr. Blagosklonny’s perspective

BUFFALO, NY- May 11, 2022 – A new research perspective was published in Oncoscience journal by Mikhail Blagosklonny, M.D., Ph.D., entitled, “Altos Labs and the quest for immortality: but can we live ...
FierceBiotech

Despite blockbuster Altos funding, longevity-focused investment drops by $1B: report

You might have assumed that given the $2 billion launch of Altos Labs—and all the buzz the startup garnered by poaching GSK R&D visionary Hal Barron to become CEO—that funding in longevity research ...